# A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients

> **NCT01536041** · PHASE2 · COMPLETED · sponsor: **Ono Pharma USA Inc** · enrollment: 59 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** ONO-6950
- **DRUG:** ONO-6950
- **DRUG:** Montelukast
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01536041
- **Lead sponsor:** Ono Pharma USA Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-11
- **Final completion:** —
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2014-02-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01536041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01536041, "A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01536041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*